News Releases - Tumor microenvironment

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
    • Filter by program
    About Ludwig Cancer genomics Cancer prevention Tumor biology Tumor immunology Tumor microenvironment
    View All
    How the scars of demolished brain tumors seed relapse
    September 9, 2024
    A switch for immune memory and anti-tumor immunity
    August 23, 2024
    Two-pronged attack strategy boosts immunotherapy in preclinical studies
    June 3, 2024
    AI predicts tumor-killing cells with high accuracy
    May 7, 2024
    Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
    April 24, 2024
    Ludwig Institute Scientific Director Chi Van Dang receives the 2024 AACR-Margaret Foti Award
    February 20, 2024
    Immune networks in tumors prime responses to a personalized immunotherapy
    February 6, 2024
    Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more
    January 18, 2024
    Five Ludwig Cancer Research scientists elected Fellows of the American Association for Cancer Research
    January 17, 2024
    Ludwig Chicago study uncovers potential drug target to overcome resistance to radiotherapy
    December 15, 2023
    Ludwig Institute Board Member Jedd Wolchok elected to National Academy of Medicine
    October 13, 2023
    Study shows how brain tumors make certain immune cells turn traitor
    September 27, 2023
    Ludwig Lausanne study illuminates a potentially exploitable coordination of gene expression across the tumor microenvironment
    August 3, 2023
    Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
    July 10, 2023
    Ludwig Harvard team devises platform to bring “multiplex” imaging to the clinical pathology laboratory
    June 22, 2023
    Ludwig Cancer Research study shows certain blood pressure drugs could boost the efficacy of cancer immunotherapy
    June 7, 2023
    Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy
    May 26, 2023
    Ludwig Lausanne’s Douglas Hanahan elected Foreign Member of the Royal Society
    May 10, 2023
    Ludwig Cancer Research scientists to present at AACR Annual Meeting
    April 17, 2023
    Two Ludwig Cancer Research studies reveal essential role of neutrophils in immunotherapy
    March 30, 2023
    Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors
    January 23, 2023
    Ludwig Cancer Research study uncovers novel aspect of tumor evolution and potential targets for therapy
    January 5, 2023
    Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
    November 17, 2022
    Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors in preclinical studies
    October 27, 2022
    Ludwig Lausanne researchers develop strategy to noninvasively monitor key immune cells in tumors
    October 19, 2022
    Richard White joins Ludwig Oxford Branch
    October 14, 2022
    Ludwig Lausanne study identifies potential combination therapy for testing in deadly brain cancer
    September 20, 2022
    Ludwig Tumor Atlas: Profiling of the tumor microenvironment to improve diagnosis and therapy
    March 15, 2022
    Study led by Ludwig researchers identifies strategy to overcome colorectal cancer resistance to immunotherapy
    November 9, 2021
    Ludwig Cancer Research study identifies cellular interactions essential to the immune attack on ovarian tumors
    November 5, 2021
    Ludwig Lausanne study shows how tumors turn immune cells into enablers of their growth
    October 25, 2021
    Ludwig Lausanne study identifies potential combination therapy for brain metastases of breast cancer
    October 18, 2021
    Ludwig Lausanne Director George Coukos receives 2021 ESMO Translational Research Award
    September 17, 2021
    Ludwig MIT study identifies new targets for cancer vaccines
    September 16, 2021
    Ludwig Lausanne researchers show a little radiation goes a long way in heating up cold tumors
    September 9, 2021
    Ludwig Cancer Research welcomes Mikaël Pittet to Ludwig Lausanne
    August 4, 2021
    Ludwig Chicago study shows vitamin A derivative enhances tumor-killing effects of radiotherapy
    June 21, 2021
    Ludwig Cancer Research study reveals how certain immune cells in body cavities help suppress anti-tumor immunity
    June 10, 2021
    Ludwig Cancer Research study discovers how to revive potent but inert anti-cancer immune cells for therapy
    May 24, 2021
    Ludwig Cancer Research scientists to present advances in immunotherapy, cancer metabolism, metastasis and detection at first AACR Annual Meeting 2021
    April 10, 2021
    Ludwig Cancer Research study uncovers metabolic vulnerability in suppressive immune cells that may be targeted for cancer immunotherapy
    February 15, 2021
    A better test for the tumor-targeting of CAR-T therapies
    November 6, 2020
    Ludwig Lausanne’s Ping-Chih Ho named Lloyd J. Old STAR researcher
    August 5, 2020
    Ludwig Cancer Research study finds reprogramming of immune cells enhances effects of radiotherapy in preclinical models of brain cancer
    July 15, 2020
    Ludwig Lausanne study charts the immune landscape of multiple brain cancers
    May 28, 2020
    Five Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
    May 14, 2020
    Targeting turncoat immune cells to treat cancer
    February 17, 2020
    Ping-Chih Ho appointed Associate Member of Ludwig Institute for Cancer Research
    January 9, 2020
    Ludwig Lausanne’s Ping-Chih Ho named an EMBO Young Investigator
    November 13, 2019
    Ludwig Oxford’s Sir Peter Ratcliffe wins Nobel Prize
    October 7, 2019
    Aggressive brain cancers tap into neural wiring to thrive
    September 27, 2019
    Ludwig study identifies an Achilles heel of many types of cancer
    August 22, 2019
    New ‘don’t eat me’ signal may provide basis for cancer therapies
    July 31, 2019
    Normalizing the tumor microenvironment to improve immunotherapy of cancer
    June 19, 2019
    Nanobodies to detect and target tumors
    May 15, 2019
    Heating up cold tumors
    January 21, 2019
    Strategies to investigate and target the tumor microenvironment
    October 20, 2018
    Johanna Joyce appointed Member of Ludwig Institute for Cancer Research, Lausanne
    October 4, 2018
    How might baking soda boost cancer therapy?
    May 31, 2018
    Ludwig scientists share new findings on personalized cancer treatments, immunotherapy and the tumor microenvironment at 2018 AACR annual meeting
    April 11, 2018
    Ludwig researchers uncover novel mechanism by which tumors evade a variety of cancer immunotherapies
    November 10, 2017
    Why some people with pancreatic cancer live longer than others
    November 9, 2017
    Ludwig presence at 2017 Society for Immunotherapy of Cancer Annual Meeting
    November 6, 2017
    Convergence of the circadian clock and cancer
    October 19, 2017
    Scale and complexity of hypoxia signaling pathways and their implications for cancer
    October 10, 2017
    Ludwig scientists discover complex axis of immune suppression exploited by cancers
    September 19, 2017
    Ludwig scientists shared data on clinical and other studies at 2017 International Cancer Immunotherapy Conference
    September 11, 2017
    Johanna Joyce elected to EMBO
    June 16, 2017
    Ludwig scientists reveal new advances in immunotherapy, predictive biomarkers and overcoming treatment resistance at 2017 AACR annual meeting
    March 29, 2017
    Johanna Joyce is part of a winning team for Cancer Research UK’s Grand Challenge award
    February 10, 2017
    Ludwig study reveals why cancer cells spread within the body
    January 16, 2017
    Chi Van Dang appointed Scientific Director of the Ludwig Institute for Cancer Research
    December 20, 2016
    Ludwig researchers show how a targeted drug overcomes suppressive immune cells
    November 9, 2016
    Ludwig researchers show how a brain tumor’s greed for cholesterol could be exploited for cancer therapy
    October 13, 2016
    Ludwig congratulates Sir Peter Ratcliffe on his receipt of the 2016 Albert Lasker Basic Medical Research Award
    September 13, 2016
    Ludwig researchers discover how cancer cells gum up the trigger of a T cell attack
    July 26, 2016
    Ludwig researchers showcase new findings on immunotherapy, liquid biopsies and other aspects of cancer care at the 2016 Annual Meeting of the American Society of Clinical Oncology
    April 12, 2016
    Ludwig presence at the 2016 AACR annual meeting
    April 12, 2016
    Ludwig scientists named to Thomson Reuters’ list of world’s most influential scientific minds
    February 18, 2016
    Ludwig San Diego’s Paul Mischel elected Fellow of the American Association for the Advancement of Science
    November 23, 2015
    Ludwig scientists to present advancements in immunotherapy, diagnostics, cell biology and genomics at 2015 AACR annual meeting
    April 14, 2015
    Ludwig presence at 2015 AACR annual meeting
    April 13, 2015
    Ludwig Harvard Director Joan Brugge receives Susan G. Komen Brinker Award for Scientific Distinction
    September 10, 2014
    New ways to treat solid tumors
    August 15, 2014
    Five Ludwig researchers named AACR fellows
    April 2, 2014
    Ludwig scientists to present advancements in immunotherapy, genomics and metastasis at 2014 AACR annual meeting
    April 2, 2014
    Ludwig presence at 2014 AACR annual meeting
    April 2, 2014
    Ludwig Oxford scientist Peter Ratcliffe receives Wiley Prize in Biomedical Sciences
    February 5, 2014
    Ludwig Cancer Research bestows half a billion in new funding to six eminent U.S. research institutions
    January 6, 2014
    Ludwig Center directors comment on the impact of the $540 million gift from Ludwig Cancer Research
    January 6, 2014
    Novel blood test for predicting response to cancer therapy to be commercialized by Ludwig start-up Serametrix Corporation
    December 9, 2013
    Ludwig presents advancements in immunotherapy and epigenetics at AACR meeting
    April 10, 2013
    Ludwig cancer researchers honored among first class of fellows in AACR Academy
    March 26, 2013
    Distinguished researcher Peter Ratcliffe joins Ludwig Institute
    November 8, 2012
    Anti-cancer vaccine using T. cruzi parasite prevents cancer in pre-clinical studies
    January 12, 2012
    Ludwig Institute partner company, Circadian, commences first phase 1 clinical trial of VEGF-C antibody VGX-100 in cancer patients
    January 10, 2012
       Back to News

    Stay In Touch

    Notice
    ?

    You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

    Continue
    Cancel